| Q36228888 | A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant |
| Q73395782 | A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions |
| Q36365446 | An essential role for gp39, the ligand for CD40, in thymic selection. |
| Q34120472 | Antibody-based immunotherapy for malignant glioma |
| Q61853724 | B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation |
| Q81499664 | B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner |
| Q56908531 | B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation |
| Q36366300 | Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion |
| Q51840948 | CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells. |
| Q33664107 | CD28/CTLA-4 and CD80/CD86 families: signaling and function |
| Q36369151 | CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade |
| Q40986859 | CD40 and its ligand in host defense |
| Q77513475 | CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis |
| Q36400640 | CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum |
| Q58882277 | CD40 ligand-transduced co-stimulation of T cells in the development of helper function |
| Q36454460 | CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge |
| Q37696199 | CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis |
| Q41134276 | CD40-CD40 ligand: a multifunctional receptor-ligand pair. |
| Q40883636 | CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency |
| Q34082784 | CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. |
| Q51381689 | CD40L is transferred to antigen-presenting B cells during delivery of T-cell help. |
| Q73427456 | CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells |
| Q44356509 | Cloning, expression and biological function of the bovine CD40 homologue: role in B-lymphocyte growth and differentiation in cattle |
| Q40124936 | Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine |
| Q40109543 | Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells. |
| Q37684852 | Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut? |
| Q35939463 | Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection |
| Q56907039 | Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis |
| Q74179292 | Cross talk between T and B cells generates B antigen-presenting cells able to induce inositol phosphate production in T cells responding to Mls(a) superantigens |
| Q39739685 | Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression |
| Q47105296 | Despite disorganized synapse structure, Th2 cells maintain directional delivery of CD40L to antigen-presenting B cells |
| Q56907315 | Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue |
| Q35839888 | Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production |
| Q40628569 | Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen |
| Q77802794 | Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity |
| Q52039725 | Expression and co-stimulatory function of B7-2 on murine CD4+ T cells. |
| Q37365656 | Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection |
| Q47877434 | Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). |
| Q28589705 | ICOS is critical for CD40-mediated antibody class switching |
| Q46716712 | IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE). |
| Q36367256 | Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. |
| Q34367466 | Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand |
| Q37358432 | Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes |
| Q53003813 | Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA+ T cells with dendritic cells. |
| Q40938938 | Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells |
| Q33712943 | Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa |
| Q39023294 | Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle |
| Q54396413 | Interactions between T lymphocytes and endothelial cells in allograft rejection. |
| Q42951672 | Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice |
| Q44628104 | Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA |
| Q33818700 | Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis |
| Q36375765 | Lineage-restricted function of nuclear factor kappaB-inducing kinase (NIK) in transducing signals via CD40. |
| Q34471729 | Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation |
| Q41049046 | Mechanisms underlying T-cell tolerance |
| Q38376339 | Methodologies for the Analysis of HCV-Specific CD4(+) T Cells |
| Q28347536 | NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells |
| Q39752406 | NF-κB Is Involved in Regulation of CD40 Ligand Expression onMycobacterium bovisBacillus Calmette-Guérin-Activated Human T Cells |
| Q77402569 | Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia |
| Q33541431 | On costimulatory signals and T cell tolerance: relevance for transplantation immunity. |
| Q42326925 | Orally tolerant CD4 T cells respond poorly to antigenic stimulation but strongly to direct stimulation of intracellular signaling pathways |
| Q56909292 | Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule |
| Q36007588 | Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner |
| Q34170759 | Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells |
| Q89700562 | Prohibitin: a potential therapeutic target in tyrosine kinase signaling |
| Q36514204 | Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes. |
| Q35028895 | Prospects for CD40-directed experimental therapy of human cancer |
| Q41275876 | Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. |
| Q73361332 | Selective Regulation of Mature IgG1 Transcription by CD86 and β2-Adrenergic Receptor Stimulation |
| Q79366608 | Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation state |
| Q73347843 | Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction |
| Q42982397 | Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro |
| Q46487226 | T cell-mediated elimination of B7.2 transgenic B cells |
| Q42944002 | TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation |
| Q77319529 | Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer-doxorubicin conjugates directed against different T-cell surface antigens |
| Q34354116 | The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules |
| Q41361342 | The CD40 ligand. At the center of the immune universe? |
| Q41587176 | The CD40-CD154 system in anti-infective host defense |
| Q33745206 | The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease |
| Q35596631 | The CD40/CD40L costimulatory pathway in inflammatory bowel disease |
| Q36371081 | The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. |
| Q36483852 | The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome |
| Q42846482 | The role of polar interactions in the molecular recognition of CD40L with its receptor CD40 |
| Q41021909 | Therapeutic potential for blockade of the CD40 ligand, gp39. |
| Q39437920 | siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions |